Signum Life Science ApS: Financial statements 2025
CVR: 36559241
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589. The solvency ratio was 71.8%. The company had 43 employees in the financial year.
- Gross Profit
- DKK -67,441,461
- Profit/Loss
- DKK -66,049,966
- Equity
- DKK 40,680,589
- Total Assets
- DKK 56,661,472
- Employees
- 43
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -67.4M | -66M | 40.7M | 43 |
| 2024 | - | -1.9M | -5.9M | 106.8M | 41 |
| 2023 | - | 1.5M | -3.1M | 112.7M | 41 |
| 2022 | - | -184K | -11.3M | 115.8M | 36 |
| 2021 | - | 7.6M | 1.3M | 128.5M | 34 |
Official annual report
How creditworthy is Signum Life Science ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 1, 2025, Henrik Vestergaard is registered as adm. dir. of Signum Life Science ApS.
As of September 30, 2025, Ida Sofie Jensen has stepped down as adm. dir. of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2024. Gross profit came to DKK -1,866,160, and the net result was DKK -5,936,982.
As of April 14, 2025, Julie Enevold Brooker has joined the board of directors of Signum Life Science ApS.
As of April 14, 2025, Anja Cecilie Verhaug has joined the board of directors of Signum Life Science ApS.
As of April 14, 2025, Thomas Bo Bjørn Klee has left the board of directors of Signum Life Science ApS.
As of April 14, 2025, Mari-Ann Retz has left the board of directors of Signum Life Science ApS.
About Signum Life Science ApS
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.
